Lilly World's Best-Selling Drug: Is the Stock a Buy Now?
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Compare ongoing fees across top dividend ETFs for 2024 to find the funds with the lowest drag on your returns and best value.
28,084 articlesEli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
A high-profile inmate known as the Gilgo Beach serial killer is spending years in isolation, reading crime fiction, a...
Former BitMEX CEO Arthur Hayes appears to be adding more ETH as critics circle over recent token hype and sales. Look...
Federal prosecutors have opened a grand jury investigation into allegations surrounding UAW President Shawn Fain, wit...
Micron has surged into a market-defining position as traders weigh earnings potential against memory-price risk. Anal...
Across Chicago and beyond, AI readiness in schools mirrors economic divides. This report examines funding gaps, acces...
Ripple advances toward a national bank charter, triggering headlines and trading shifts for XRP. Experts weigh how wh...
Taylor Swift’s ascent to a $2 billion fortune redefines wealth in music. This article unpacks how she built this empi...
A glamorous opal suite with a surprising backstory sheds light on how provenance, rarity, and celebrity connections c...
A former chief staff mayor to NYC Mayor Eric Adams has been arrested on bribery and fraud charges, part of a widening...
Hyperliquid Strategies’ billion hype treasury trade moves into public markets, as liquidity remains untested and inve...
On the nation’s 250th birthday, economists and market experts outline ten reasons why America’s economy looks poised ...